{"disease":{"id":"eczema","name":"Eczema","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":4,"pipeline_drug_count":0,"trial_count":7},"drugs":{"marketed":[{"drug_id":"tacrolimus","indication_name":"Intractable Eczema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prograf","generic_name":"TACROLIMUS","company_name":"Astellas Pharma","drug_phase":"marketed","molecular_target":"Interferon gamma","drug_class":"Calcineurin Inhibitor Immunosuppressant","quality_score":80,"revenue":"1600","mechanism":"Prograf works by inhibiting the activation of T-lymphocytes, a type of immune cell."},{"drug_id":"fluocinolone-acetonide","indication_name":"Otitis Externa Eczema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Derma-Smoothe/Fs","generic_name":"FLUOCINOLONE ACETONIDE","company_name":"Eurofarma","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone","indication_name":"Otitis Externa Eczema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Decadron","generic_name":"dexamethasone","company_name":"Generic (originally Merck)","drug_phase":"marketed","molecular_target":"Annexin A1, Interleukin-4, Androgen receptor","drug_class":"Corticosteroid [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"lanolin","indication_name":"Eczema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Veradex-E","generic_name":"LANOLIN","company_name":"ABBE Laboratories, Inc.","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"dexpanthenol","indication_name":"Eczema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Infuvite Adult","generic_name":"DEXPANTHENOL","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"dexpanthenol","quality_score":38,"revenue":null,"mechanism":""},{"drug_id":"pimecrolimus","indication_name":"Intractable Eczema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Elidel","generic_name":"PIMECROLIMUS","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Peptidyl-prolyl cis-trans isomerase FKBP1A","drug_class":"Calcineurin Inhibitor Immunosuppressant [EPC]","quality_score":75,"revenue":null,"mechanism":"Elidel works by inhibiting calcineurin, a protein that helps activate T-cells, which are involved in the allergic response."},{"drug_id":"clobetasone-butyrate","indication_name":"Eczema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Eumovate","generic_name":"CLOBETASONE BUTYRATE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"clobetasol-propionate","indication_name":"Nummular eczema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Temovate","generic_name":"CLOBETASOL PROPIONATE","company_name":"Fougera Pharms","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":39,"revenue":null,"mechanism":""},{"drug_id":"bepanthen","indication_name":"Eczema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Bepanthen","company_name":"RWTH Aachen University","drug_phase":"phase_3","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":9,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03823794","title":"Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK)","phase":"","overall_status":"COMPLETED","enrollment_count":148166,"lead_sponsor_name":"Momentum Data","has_results":true},{"nct_id":"NCT05316805","title":"China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT04375410","title":"Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic","phase":"","overall_status":"COMPLETED","enrollment_count":6273,"lead_sponsor_name":"Regionshospital Nordjylland","has_results":false},{"nct_id":"NCT03192748","title":"A Registry Study of Runzaozhiyang Capsule Used in Clinical Real World","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"China Academy of Chinese Medical Sciences","has_results":false},{"nct_id":"NCT06583395","title":"Quest to Analyze One Thousand Humans Meditating","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":3000,"lead_sponsor_name":"Tobias Moeller-Bertram","has_results":false},{"nct_id":"NCT05473325","title":"Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Willows Health","has_results":false},{"nct_id":"NCT05439577","title":"A Multicentre Study to Explore the Efficacy and Safety of Mucopolysaccharide Polysulfate Cream in Patients With Eczema","phase":"","overall_status":"UNKNOWN","enrollment_count":1800,"lead_sponsor_name":"Shenzhen Kangzhe Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT03461848","title":"CYPHP Evelina London Evaluation","phase":"NA","overall_status":"COMPLETED","enrollment_count":1731,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT04680520","title":"Barrier Enhancement for Eczema Prevention","phase":"NA","overall_status":"COMPLETED","enrollment_count":1394,"lead_sponsor_name":"University of Nottingham","has_results":false},{"nct_id":"NCT03409367","title":"A Community-based Assessment of Skin Care, Allergies, and Eczema","phase":"NA","overall_status":"COMPLETED","enrollment_count":1260,"lead_sponsor_name":"Oregon Health and Science University","has_results":true},{"nct_id":"NCT03627767","title":"Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1235,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04804605","title":"Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1220,"lead_sponsor_name":"Arcutis Biotherapeutics, Inc.","has_results":true},{"nct_id":"NCT04031469","title":"A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease","phase":"","overall_status":"SUSPENDED","enrollment_count":1000,"lead_sponsor_name":"ProgenaBiome","has_results":false},{"nct_id":"NCT05938478","title":"Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT","phase":"","overall_status":"RECRUITING","enrollment_count":900,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT03720470","title":"Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":838,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04949841","title":"Open-label Multi-site Extension Trial in Subjects Who Completed the DELTA 1 or DELTA 2 Trials","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":801,"lead_sponsor_name":"LEO Pharma","has_results":true},{"nct_id":"NCT05330637","title":"Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.","phase":"","overall_status":"UNKNOWN","enrollment_count":800,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT03667651","title":"The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":760,"lead_sponsor_name":"University of Melbourne","has_results":false},{"nct_id":"NCT04773600","title":"Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":683,"lead_sponsor_name":"Arcutis Biotherapeutics, Inc.","has_results":true},{"nct_id":"NCT04773587","title":"Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":654,"lead_sponsor_name":"Arcutis Biotherapeutics, Inc.","has_results":true},{"nct_id":"NCT04845620","title":"Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":652,"lead_sponsor_name":"Arcutis Biotherapeutics, Inc.","has_results":true},{"nct_id":"NCT06072287","title":"The Living With a Long-Term Condition Study","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"King's College London","has_results":false},{"nct_id":"NCT00817063","title":"Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":599,"lead_sponsor_name":"Stiefel, a GSK Company","has_results":true},{"nct_id":"NCT04809571","title":"Non-invasive Photoacoustic Imaging of Skin Inflammatory Disorders With Machine Learning-assisted Scoring","phase":"NA","overall_status":"UNKNOWN","enrollment_count":550,"lead_sponsor_name":"Institute of Bioengineering and Bioimaging (IBB)","has_results":false},{"nct_id":"NCT00605878","title":"Studies of Skin Microbes in Healthy People and in People With Skin Conditions","phase":"","overall_status":"RECRUITING","enrollment_count":530,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT05259722","title":"A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":513,"lead_sponsor_name":"LEO Pharma","has_results":true},{"nct_id":"NCT03621137","title":"TREAT NL (TREatment of ATopic Eczema, the Netherlands) Registry: Dutch National Registry for Patients With Moderate-to-severe Atopic Eczema on Photo- or Systemic Therapies","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT04871711","title":"Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":487,"lead_sponsor_name":"LEO Pharma","has_results":true},{"nct_id":"NCT04872101","title":"Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":473,"lead_sponsor_name":"LEO Pharma","has_results":true},{"nct_id":"NCT04154839","title":"Epidemiological Survey and Genetic Analysis of AD Patients in Hong Kong","phase":"","overall_status":"UNKNOWN","enrollment_count":450,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT03077191","title":"Toxicity and Outcome of Whole Breast Hypofractionated Radiotherapy: a Single Institution Experience","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":410,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT06554847","title":"Evaluation of 611 in Combination With Topical Corticosteroid in Participants With Moderate to Severe Atopic Dermatitis","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.","has_results":false},{"nct_id":"NCT03742414","title":"Seal, Stopping Eczema and Allergy Study","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":398,"lead_sponsor_name":"Kari Nadeau, MD, PhD","has_results":false},{"nct_id":"NCT05131477","title":"Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":390,"lead_sponsor_name":"Kymab Limited","has_results":true},{"nct_id":"NCT06004050","title":"A Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Delgocitinib Cream in Chinese Adults and Adolescents With Moderate to Severe Chronic Hand Eczema","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":362,"lead_sponsor_name":"LEO Pharma","has_results":false},{"nct_id":"NCT05149313","title":"A Study of Lebrikizumab in Combination With Topical Corticosteroids in Patients With Atopic Dermatitis (AD) That Are Not Adequately Controlled With or Are Non-eligible for Cyclosporine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":331,"lead_sponsor_name":"Almirall, S.A.","has_results":true},{"nct_id":"NCT03871998","title":"Short-term Topical Application to Prevent Atopic Dermatitis","phase":"NA","overall_status":"COMPLETED","enrollment_count":321,"lead_sponsor_name":"University College Cork","has_results":false},{"nct_id":"NCT01257061","title":"Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatment","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":310,"lead_sponsor_name":"EMS","has_results":false},{"nct_id":"NCT03981926","title":"Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis","phase":"NA","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"University of Southern California","has_results":true},{"nct_id":"NCT06464133","title":"Investigation of Filaggrin Gene Mutations Among Latinx Patients With Atopic Dermatitis","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":300,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT03134352","title":"Study to Evaluate the Efficacy and Safety of ZL-3101 in Subjects With Subacute Eczema","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":290,"lead_sponsor_name":"Zai Lab Pty. Ltd.","has_results":false},{"nct_id":"NCT04760314","title":"A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":286,"lead_sponsor_name":"Eli Lilly and Company","has_results":true},{"nct_id":"NCT06529913","title":"Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases","phase":"NA","overall_status":"RECRUITING","enrollment_count":280,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT05026554","title":"Characterization of Chronic Hand Eczema","phase":"","overall_status":"RECRUITING","enrollment_count":270,"lead_sponsor_name":"Dr. Robert Bissonnette","has_results":false},{"nct_id":"NCT07438509","title":"Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic Eczema","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":270,"lead_sponsor_name":"Jinnah Postgraduate Medical Centre","has_results":false},{"nct_id":"NCT03683719","title":"Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":258,"lead_sponsor_name":"LEO Pharma","has_results":true},{"nct_id":"NCT05642208","title":"Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":256,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT03054428","title":"Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":251,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT01567995","title":"Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and Safety","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"GlaxoSmithKline","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}